期刊文献+

Neurocan基因蛋白表达及其抗体制备与检测的实验研究 被引量:1

Gene express and antibody preparation of Neurocan protein
原文传递
导出
摘要 目的制备Neurocan蛋白,用此蛋白免疫动物制备抗血清,并对抗血清进行检测,最终使待参与DNA疫苗构成的Neurocan蛋白所产生的抗体能与脑内创伤区的相应抑制性蛋白抗原结合,从而减轻抑制因子对神经生长的抑制作用,促进神经再生。方法合成Neurocan基因,构建原核表达质粒PET30a-Neurocan,转化大肠杆菌BL21,异丙基-β—D-硫代半乳糖苷(IPTG)诱导表达目的蛋白,并经SDS—PAGE、Western blot鉴定。Neurocan蛋白免疫兔制备免疫血清。ELISA法检测抗血清效价,以兔免疫前血清为阴性对照:Western blot检测抗血清特异性,以免疫血清为-抗,山羊抗兔-AP为二抗,NBT/BCIP显色。结果合成的Areurocart基因经酶切鉴定、PCR鉴定及测序鉴定,显示序列正确。原核表达Neurocan蛋白经过SDS-PAGE鉴定,条带大小约为55000,与计算出来的大小一致;经Westem blot鉴定,目的蛋白能与his抗体特异性结合,说明是Neurocan基因的表达产物。抗血清经ELISA法检测,抗血清效价达到1:100万;经Western blot检测,目的条带明显。结论Neurocan蛋白原核表达成功;通过Neurocan蛋白免疫兔可得到特异性抗体,此抗体能与Neurocan蛋白特异性结合,为DNA疫苗的进一步研制奠定了基础。 Objective To offered some prophase works by preparing Neurocan protein, antiserum, and assaying their characteristics, in order to construct the isopropy-β-D-thiogalaetoside (IPTG)-participated DNA vaccine, which can neutralize the inhibitors in the injured CNS following the immune administration and then promote the nerve regeneration. Methods Neurocan gene was synthetized with HisTag label in beginning and enzyme-cut sites at amphi- of the sequence. The prokaryotic expression plasmid, PET30a-Neurocan, was constructed as usual, converted into the Escherichia coli, and induced by IPTG to express positively. The interest protein was identified by SDS-PAGE and Western blot respectively. The preimmune serum was as the negative control during the ELISA assay of antiserum valency. The immune serum was as the first antibody, and the goat-anti-rabbit labeling with alkaline phosphatase (AP) was employed as the second one. Coloration was with NBT/BCIP method. Results The correct sequence of the synthetic Neurocan gene was clearly showed by identification with enzyme-cut, PCR and sequencing. The Neurocan protein expressed by prokaryotic showed its molecular weigh as 55 000 following the SDS-PAGE identification, and it could specifically bind with anti-HisTag, which implied the interesting protein just as the expression product of Neurocan gene. The valency of antiserum was shown by ELISA as 1 : 1 000 000, the purpose strap of which was confirmed by Western blot. Conclusions Neurocan protein could be successfully expressed in prokaryotic, the antibody of which could be specifically obtained by immune administration to the rabbit. The Neuroncan antibody could bind with the Neurocan protein specifically.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第2期109-113,共5页 Chinese Journal of Neuromedicine
基金 国家基金重点项目(U0632008) 广东省科技计划重点项目[粤财教(2008)258-2008A030201019,粤科基办(2004)08、(2007)05/06-7005206]
关键词 Neurocan基因 原核表达 抗血清 Neurocan gene Prokaryotic expression Antiserum
  • 相关文献

参考文献13

  • 1Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelinassociated neurite outgrowth inhibitor and an antigent for monoclonal antibody IN-1 [J]. Nature, 2000, 403 (6768): 434-439.
  • 2Grandpre T, Nakamura F, Vartanian T, et al. Identification of the Nogo inhibitor of axon regeneration as a reticulon protein [J]. Nature, 2000, 403(6768): 439-444.
  • 3Mukhopadhyay G, Dojerty P, Walsh FS, et al. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration[J]. Neuron, 1994, 13(3): 757-767.
  • 4McKerracher L, David S, Jackson DL, et al. Identification of myelin-associated glycoprotein as a majior myelin-derived inhibitor ofneurite growth[J]. Neuron, 1994, 13(4): 805-811.
  • 5Mikol DD, Stefansson K. A phosphatidylinositol-linked peanut agglutinin-binding glycoprotein in central nervous system myelin and on oligodendrocytes [J]. J Cell Biol, 1988, 106 (4): 1273-1279.
  • 6Mikol DD, Gulcher JR, Stefansson K. The oligodendrocyte-myelin glycoprotein belongs to a distinct family of proteins and contains the HNK-1 carbohydrate[J]. J cell Biol, 1990, 110(2): 471-479.
  • 7Mi S, Lee X, Shao Z, et al. LINGO-1 is a omponent of the Nogo-66 receptor/p75 signaling complex [J]. Nat Neurosci, 2004, 7 (3): 221-228.
  • 8Park JB, Yiu G, Kaneko S, et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors[J]. Neuron, 2005, 45 (3): 345-351.
  • 9Properzi F, Fawcett JW. Proteoglycans and brain repair[J]. News Physiol Sci, 2004, 19: 33-38.
  • 10Angelov DN, Walther M, Streppel M, et al. Tenascin-R is antiadhesive for activated microglia that induce down regulation of the protein after peripheral nerve injury: a new role in neuronal protection [J]. J Neurosci, 1998, 18 (16): 6218-6229.

二级参考文献34

  • 1吕爱平.关节软骨免疫与类风湿性关节炎——Ⅱ型胶原所致免疫性关节炎发病机制[J].中国中医基础医学杂志,2000,6(5):1-5. 被引量:15
  • 2李宝丽,唐方,庞晓东.Ⅱ型胶原诱导关节炎大鼠模型制备[J].中国免疫学杂志,2006,22(4):350-352. 被引量:39
  • 3姜旭淦,陈盛霞,丁建霞,王卉放,马洁,吴亮,许化溪.猪软骨Ⅱ型胶原蛋白的提取纯化与鉴定[J].江苏大学学报(医学版),2006,16(5):389-391. 被引量:17
  • 4姜旭淦,陈盛霞,王卉放,吴亮,许化溪.可溶性Ⅱ型胶原蛋白提取纯化条件的研究[J].临床检验杂志,2006,24(6):418-421. 被引量:13
  • 5Raineteau O, Schwab ME. Plasticity of motor systems after incomplete spinal cord injury[J]. Nat Rev Neurosci, 2001, 2(4):263-273.
  • 6Ang BT, Xu G, Xiao ZC. Therapeutic vaccination for central nervous system [J]. Clin Exp Pharmacol Physol, 2006, 33 (5-6):567-571.
  • 7Xu G, Nie DY, Wang WZ, et al. Optic nerve regeneration in polyglycolic acid-chitosan conduits coated with recombinant L1-Fc[J]. Neuroreport, 2004, 15(14): 2167-2172.
  • 8Chen MS, Huber AB, van der Haar ME, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigent for monoclonal antibody IN-1 [J]. Nature, 2000, 403(6768): 433-439.
  • 9Domeniconi M, Cao Z, Spencer T, et al. Myelin-associated glycoprotein interacts with the Nogo-66 receptor to inhibit neurite outgrowth[J]. Neuron, 2002, 35(2): 283-290.
  • 10Yamashita T, Higuchi H, Tohyama M. The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho [J]. J Cell Biol, 2002, 157(4): 565-570.

共引文献10

同被引文献11

  • 1姜晓丹,肖志成.中枢神经系统损伤修复与治疗性疫苗[J].中华神经医学杂志,2007,6(3):217-220. 被引量:4
  • 2Huang JK,Phillips GR,Roth AD,et al.Glial membranes at the node of Ranvier prevent neurite outgrowth[J].Science,2005,310(5755):1813-1817.
  • 3Schnell L,Schwab ME.Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors[J].Nature,1990,343(6255):269-272.
  • 4Freund P,Wannier T,Schmidlin E,et al.Anti-Nogo-A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey[J].JComp Neurol,2007,502(4):644-659.
  • 5Huang DW,McKerracher L,Braun PE,et al.A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord[J].Neuron,1999,24(3):639-647.
  • 6Xu G,Nie DY,Chen JT,et al.Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth:a potential strategy for axonal regeneration[J].J Neurochem,2004,91(4):1018-1023.
  • 7Beaud ML,Schmidlin E,Wannier T,et al.Anti-Nogo-A antibody treatment does not prevent cell body shrinkage in the motor cortex in adult monkeys subjected to unilateral cervical cord lesion[J].BMC Neurosci,2008,9:5.
  • 8Xie F,Zheng BH.White matter inhibitors in CNS axon regeneration failure[J].Exp Neurol,2008,209(2):302-312.
  • 9Zheng B,Atwal J,Ho C,et al.Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo[J].Proc Natl Acad Sci USA,2005,102(4):1205-1210.
  • 10Song XY,Zhong JH,Wang X,et al.Suppression of p75NTR does not promote regeneration of injured spinal cord in mice[J].JNeurosci,2004,24(2):542-546.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部